Ameliorative effect of vasopressin-(4–9) through vasopressin V1A receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze

Abstract In order to clarify the mechanism by which pGlu-Asn-Cys(Cys)-Pro-Arg-Gly-NH 2 (vasopressin-(4–9)), a major metabolite C-terminal fragment of [Arg 8 ]-vasopressin (vasopressin-(1–9)), improves learning and memory, we used several different drugs such as an acetylcholine receptor antagonist, a Ca 2+ /calmodulin-dependent protein kinase II inhibitor, vasopressin receptor antagonists and L-type Ca 2+ channel blocker to disrupt spatial memory in rats. Moreover, we examined the effect of vasopressin-(4–9) on acetylcholine release in the ventral hippocampus using microdialysis. Vasopressin-(4–9) (10 fg/brain, i.c.v.) improved the impairment of spatial memory in the eight-arm radial maze induced by scopolamine, pirenzepine and Ca 2+ /calmodulin -dependent protein kinase II inhibitor. Pirenzepine, a vasopressin V 1A receptor antagonist, and L-type Ca 2+ channel blocker, but not a vasopressin V 2 receptor antagonist, suppressed the effects of vasopressin-(4–9) on scopolamine-induced impairment of spatial memory. Moreover, vasopressin-(4–9) did not affect acetylcholine release in the ventral hippocampus of intact rats or of scopolamine-treated rats as assessed by microdialysis. These results suggest that vasopressin-(4–9) activates vasopressin V 1A receptors on the postsynaptic membrane of cholinergic neurons, and induces a transient influx of intracellular Ca 2+ through L-type Ca 2+ channels to interact with muscarinic M 1 receptors. The activation of these processes by vasopressin-(4–9) is critically involved in the positive effect of vasopressin-(4–9) on scopolamine-induced impairment of spatial memory.